choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Treanda

Treanda Newsletter
  • <![CDATA[Pirtobrutinib Wins Traditional FDA Approval in CLL and SLL]]> 03 Dec 2025 19:41 GMT

    … Rituxan; IR) or bendamustine (Treanda) plus rituximab (BR). Notably … ;2 trial whose disease progressed following treatment with a … Wierda is professor, medical director, and CLL … www.fda.gov/drugs/;resources-information-approved-drugs/fda-grants- …

  • Unpacking the Latest Options Trading Trends in Teva Pharmaceutical Indus 30 Sep 2025 20:18 GMT

    … has a portfolio of innovative medicines and biosimilars in three main … , and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract … US-based generic and specialty drug distributor. After a thorough review …

  • <![CDATA[Determining Fitness Is Key in Mantle Cell Lymphoma Treatment Selection]]> 23 Sep 2025 21:53 GMT

    … combinations that include bendamustine (Treanda) and rituximab (Rituxan) … Medicine (Hematology) at Yale University. Transcript: The current treatment … changed among most lymphoma doctors. That is based … although we have clinical trials ongoing here, so we …

  • Pirtobrutinib Improves PFS in Treatment-Naïve CLL/SLL Without 17p Deletions 08 Sep 2025 18:25 GMT

    … 313 trial (NCT05023980) that evaluated pirtobrutinib monotherapy vs bendamustine (Treanda) plus … consistent with previously reported trials across various treatment settings. "The … study [NCT05254743], at upcoming medical meetings and preparing global …

  • A Glimpse of Teva Pharmaceutical Indus's Earnings Potential 29 Jul 2025 17:23 GMT

    … has a portfolio of innovative medicines and biosimilars in three main … , and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract … -based generic and specialty drug distributor. Teva Pharmaceutical Indus's Financial …

  • Treanda (bendamustine) and cost 30 May 2025 14:40 GMT

    … and your doctor will discuss Treanda in regard to your treatment. The insurance … your doctor or another healthcare professional before taking any medication. The drug information …

  • Where Teva Pharmaceutical Indus Stands With Analysts 28 May 2025 22:33 GMT

    … Pharmaceutical Indus Teva Pharmaceutical Industries, based in Israel, is the leading generic drug … has a portfolio of innovative medicines and biosimilars in three … and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract …

  • Treanda side effects and how to manage them 06 May 2025 15:22 GMT

    … FDA) approves a drug, it tracks and reviews side effects of the medication … side effects during Treanda treatment, call your doctor right away. If … vaccinations before starting Treanda. Your doctor will help determine what vaccines you may need. Treanda …

  • <![CDATA[Subcutaneous Mosunetuzumab Earns EU Approval in R/R Follicular Lymphoma]]> 22 Nov 2025 05:00 GMT

    … the world, including the FDA. Additionally, investigators plan to … new formulations of our medicines is part of our … line of treatment were eligible for enrollment on the trial. Other … bendamustine (Treanda); or obinutuzumab plus bendamustine.3 The trial’s …

  • Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 With Key Innovative Medicines Growing ~40%; 2025 Profit Outlook Improved 07 May 2025 11:00 GMT

    …     396     282   40% BENDEKA and TREANDA             36     46   (20%) COPAXONE … FDA approved AUSTEDO XR as a one pill, once-daily treatment … market. The orphan drug exclusivity that had … and innovative medicines and OTC pharmaceutical products from Teva …

Satisfied with the content?

Continue to create your account.